Xinri Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xinri Zhang has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
Dawei Cao
NHC Key Laboratory of Pneumoconiosis, Shanxi Key Laboratory of Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, China
7 shared publicationsHuiqing Shen
Department of Pulmonary and Critical Care Medicine, NHC Key Laboratory of Pneumoconiosis, Shanxi Key Laboratory of Respiratory Diseases, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
6 shared publicationsGuangyuan Jiao
Department of Ideological and Political Education, School of Marxism, Capital Medical University, Beijing 102200, China
4 shared publicationsHantian Dong
First Department of Geriatric Diseases, First Hospital of Shanxi Medical University, Taiyuan, People’s Republic of China
4 shared publicationsJimin Sun
Key Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310000, Zhejiang, China
4 shared publications- Pengzhou Kong
School of Medical Sciences & Translational Medicine Research Center, Shanxi Key Laboratory of Precision Diagnosis and Clinical Transformation of Esophageal Cancer, Department of Pathology, Shanxi Medical University, Taiyuan, Shanxi, PR China.
4 shared publications
Latest Publications
- 8 April 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 197 (7) , 4368-4387
Correlation Between CAV-1 and PTEN-Mediated Apoptosis in Hyperoxia-Induced Acute Lung Injury
Purpose Respiratory support is essential in the clinical management of critically ill patients; however, prolonged exposure to high concentrations of oxygen can result in hyperoxia-induced acute lung injury (HALI). In this study, we developed a model of hyperoxia exposure utilizing C57BL/6 mice and human bronchial epithelial (BEAS-2B) cells. We employed CAV-1 siRNA transfection and CAV-1 expression plasmid techniques to analyze the effects of hyperoxia on the expression of caveolin-1 (CAV-1), the deletion of the phosphatase and tensin homolog (PTEN) gene on chromosome 10, and the apoptotic markers Bax and Bcl-2. Additionally, we explored the mechanisms by which CAV-1 regulates PTEN-mediated apoptosis in the context of HALI. Our findings aim to provide valuable insights for developing effective preventive and therapeutic strategies to combat this condition. Methods First, we established a hyperoxia-induced acute lung injury (HALI) model in male C57BL/6 mice. Histopathological examination was conducted using hematoxylin–eosin staining to evaluate the pathological changes and the severity of lung tissue damage. Next, we developed an in vitro HALI model utilizing the BEAS-2B cell line. Subsequently, CAV-1 siRNA and CAV-1 expression plasmids were transfected into BEAS-2B cells. We quantified the expression levels of CAV-1, PTEN, Bax, and Bcl-2 using reverse transcription polymerase chain reaction (RT-PCR) and immunoblotting techniques. Additionally, the impact of altered CAV-1 expression on apoptosis in BEAS-2B cells was assessed through flow cytometry. Results Exposure to hyperoxia led to pathological alterations in mice’s lung tissue, increased the CAV-1, PTEN, and Bax expression levels, and decreased Bcl-2 expression. Initially, there were no notable variances in the expression levels of CAV-1, PTEN, and Bax in the cells. However, as the exposure time to hyperoxia prolonged, there was a significant increase in both mRNA and protein expression levels of CAV-1 and PTEN, while Bcl-2 exhibited a significant decrease. Moreover, CAV-1 knockdown attenuated the expression of PTEN and Bax, and elevated the expression of Bcl-2. However, CAV-1 overexpression showed an opposite result. The expression levels of CAV-1, PTEN, and Bax were positively correlated in mice and cell models, and negatively correlated with those of Bcl-2. Additionally, downregulation of CAV-1 suppressed apoptosis in BEAS-2B cells. Conclusion Our results indicate that CAV-1 plays a pivotal role in regulating the expression of PTEN and the apoptosis-related factors Bax and Bcl-2 in a hyperoxic environment. This regulatory function of CAV-1 on PTEN and its downstream apoptotic pathways suggests a significant correlation between CAV-1 and PTEN-mediated apoptosis. Consequently, CAV-1 is involved in the development of hyperoxic lung injury (HALI) through the PTEN-mediated apoptotic pathway. These findings offer new insights into the molecular mechanisms underlying the pathogenesis of HALI and underscore the potential therapeutic implications of targeting CAV-1 in the management of this condition.
- 8 April 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 197 (7) , 4368-4387
Correlation Between CAV-1 and PTEN-Mediated Apoptosis in Hyperoxia-Induced Acute Lung Injury
Purpose Respiratory support is essential in the clinical management of critically ill patients; however, prolonged exposure to high concentrations of oxygen can result in hyperoxia-induced acute lung injury (HALI). In this study, we developed a model of hyperoxia exposure utilizing C57BL/6 mice and human bronchial epithelial (BEAS-2B) cells. We employed CAV-1 siRNA transfection and CAV-1 expression plasmid techniques to analyze the effects of hyperoxia on the expression of caveolin-1 (CAV-1), the deletion of the phosphatase and tensin homolog (PTEN) gene on chromosome 10, and the apoptotic markers Bax and Bcl-2. Additionally, we explored the mechanisms by which CAV-1 regulates PTEN-mediated apoptosis in the context of HALI. Our findings aim to provide valuable insights for developing effective preventive and therapeutic strategies to combat this condition. Methods First, we established a hyperoxia-induced acute lung injury (HALI) model in male C57BL/6 mice. Histopathological examination was conducted using hematoxylin–eosin staining to evaluate the pathological changes and the severity of lung tissue damage. Next, we developed an in vitro HALI model utilizing the BEAS-2B cell line. Subsequently, CAV-1 siRNA and CAV-1 expression plasmids were transfected into BEAS-2B cells. We quantified the expression levels of CAV-1, PTEN, Bax, and Bcl-2 using reverse transcription polymerase chain reaction (RT-PCR) and immunoblotting techniques. Additionally, the impact of altered CAV-1 expression on apoptosis in BEAS-2B cells was assessed through flow cytometry. Results Exposure to hyperoxia led to pathological alterations in mice’s lung tissue, increased the CAV-1, PTEN, and Bax expression levels, and decreased Bcl-2 expression. Initially, there were no notable variances in the expression levels of CAV-1, PTEN, and Bax in the cells. However, as the exposure time to hyperoxia prolonged, there was a significant increase in both mRNA and protein expression levels of CAV-1 and PTEN, while Bcl-2 exhibited a significant decrease. Moreover, CAV-1 knockdown attenuated the expression of PTEN and Bax, and elevated the expression of Bcl-2. However, CAV-1 overexpression showed an opposite result. The expression levels of CAV-1, PTEN, and Bax were positively correlated in mice and cell models, and negatively correlated with those of Bcl-2. Additionally, downregulation of CAV-1 suppressed apoptosis in BEAS-2B cells. Conclusion Our results indicate that CAV-1 plays a pivotal role in regulating the expression of PTEN and the apoptosis-related factors Bax and Bcl-2 in a hyperoxic environment. This regulatory function of CAV-1 on PTEN and its downstream apoptotic pathways suggests a significant correlation between CAV-1 and PTEN-mediated apoptosis. Consequently, CAV-1 is involved in the development of hyperoxic lung injury (HALI) through the PTEN-mediated apoptotic pathway. These findings offer new insights into the molecular mechanisms underlying the pathogenesis of HALI and underscore the potential therapeutic implications of targeting CAV-1 in the management of this condition.
- Open Access
- 27 January 2025
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 24 (1) , 1-18
Deep learning-based algorithm for classifying high-resolution computed tomography features in coal workers’ pneumoconiosis
Coal workers’ pneumoconiosis is a chronic occupational lung disease with considerable pulmonary complications, including irreversible lung diseases that are too complex to accurately identify via chest X-rays. The classification of clinical imaging features from high-resolution computed tomography might become a powerful clinical tool for diagnosing pneumoconiosis in the future. All chest high-resolution computed tomography (HRCT) medical images presented in this work were obtained from 217 coal workers' pneumoconiosis (CWP) patients and dust-exposed workers. We segmented regions of interest according to the diagnostic results, which were evaluated by radiologists. These regions were then classified regions into four categories. We employed an efficient deep learning model and various image augmentation techniques (DenseNet-ECA). The classification performance of the different deep learning models was assessed, and receiver operating characteristic (ROC) curves and accuracy (ACC) were used to determine the optimal algorithm for classifying CWP clinical imaging features obtained from HRCT images. Four primary clinical imaging features in HRCT images, with a total of more than 1700 regions of interest (ROIs), were annotated, augmented, and used as a training set for tenfold cross-validation to generate the model. We selected DenseNet-Attention Net as the optimal model through assessing the performance of different classification algorithms, which yielded an average area under the ROC curve (AUC) of 0.98, and all clinical imaging features were classified with an AUC greater than 0.92. For the individual classifications, the AUCs were as follows: small miliary opacities, 0.99; nodular opacities, 1.0; interstitial changes, 0.92; and emphysema, 1.0. We successfully applied a data augmentation strategy to develop a deep learning model by combining DenseNet with ECA-Net. We used our novel model to automatically classify CWP clinical imaging features from 2D HRCT images. This successful application of a deep learning-data augmentation algorithm can help clinical radiologists by providing reliable diagnostic information for classification. Trial registration: Chinese Clinical Trial Registry, ChiCTR2100050379. Registered on 27 August 2021, https://www.chictr.org.cn/bin/project/edit?pid=132619 .
- 27 January 2025
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 24 (1) , 1-18
Open AccessDeep learning-based algorithm for classifying high-resolution computed tomography features in coal workers’ pneumoconiosis
Coal workers’ pneumoconiosis is a chronic occupational lung disease with considerable pulmonary complications, including irreversible lung diseases that are too complex to accurately identify via chest X-rays. The classification of clinical imaging features from high-resolution computed tomography might become a powerful clinical tool for diagnosing pneumoconiosis in the future. All chest high-resolution computed tomography (HRCT) medical images presented in this work were obtained from 217 coal workers' pneumoconiosis (CWP) patients and dust-exposed workers. We segmented regions of interest according to the diagnostic results, which were evaluated by radiologists. These regions were then classified regions into four categories. We employed an efficient deep learning model and various image augmentation techniques (DenseNet-ECA). The classification performance of the different deep learning models was assessed, and receiver operating characteristic (ROC) curves and accuracy (ACC) were used to determine the optimal algorithm for classifying CWP clinical imaging features obtained from HRCT images. Four primary clinical imaging features in HRCT images, with a total of more than 1700 regions of interest (ROIs), were annotated, augmented, and used as a training set for tenfold cross-validation to generate the model. We selected DenseNet-Attention Net as the optimal model through assessing the performance of different classification algorithms, which yielded an average area under the ROC curve (AUC) of 0.98, and all clinical imaging features were classified with an AUC greater than 0.92. For the individual classifications, the AUCs were as follows: small miliary opacities, 0.99; nodular opacities, 1.0; interstitial changes, 0.92; and emphysema, 1.0. We successfully applied a data augmentation strategy to develop a deep learning model by combining DenseNet with ECA-Net. We used our novel model to automatically classify CWP clinical imaging features from 2D HRCT images. This successful application of a deep learning-data augmentation algorithm can help clinical radiologists by providing reliable diagnostic information for classification. Trial registration: Chinese Clinical Trial Registry, ChiCTR2100050379. Registered on 27 August 2021, https://www.chictr.org.cn/bin/project/edit?pid=132619 .
- Open Access
- 26 June 2024
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 66 (10) , 826-833
Arginine-Proline Metabolism as a Mediator in the Association Between Coal Dust Exposure and Lung Function
Objectives: To investigate the mediating role of the activation degree of arginine-proline metabolism in the association of coal dust and decreased lung function. Methods: Cumulative dust exposure (CDE) represented coal dust exposure, whereas the hydroxyproline-to-arginine concentration ratio (Hyp/Arg) in bronchoalveolar lavage fluid gauged arginine-proline metabolism activation. Pulmonary function indicators, including predicted value of forced vital capacity (FVC%pred), forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC%), and the ratio of actual to predicted value of FEV1 (FEV1%pred), diffusing capacity of the lungs for carbon monoxide (DLCO%pred), difference value between alveolar air and arterial partial oxygen pressure (P(A−a) O2), and 6-minute walking distance test (6MWT), were assessed. Results: Findings revealed a significant association between elevated CDE and increased Hyp/Arg, increased P(A−a) O2, decreased 6MWT, DLCO%pred, and decreased FVC%pred. However, no statistically significant association was found between CDE and FEV1%pred or FEV1/FVC%. The mediating effect of Hyp/Arg was significant for CDE’s impact on P(A−a) O2 and DLCO%pred but not on 6MWT and FVC%pred. Conclusions: These results highlight the role of Hyp/Arg in mediating the association between CDE and lung function parameters, shedding light on potential therapeutic avenues for mitigating coal dust–induced lung function impairment.
- 26 June 2024
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 66 (10) , 826-833
Open AccessArginine-Proline Metabolism as a Mediator in the Association Between Coal Dust Exposure and Lung Function
Objectives: To investigate the mediating role of the activation degree of arginine-proline metabolism in the association of coal dust and decreased lung function. Methods: Cumulative dust exposure (CDE) represented coal dust exposure, whereas the hydroxyproline-to-arginine concentration ratio (Hyp/Arg) in bronchoalveolar lavage fluid gauged arginine-proline metabolism activation. Pulmonary function indicators, including predicted value of forced vital capacity (FVC%pred), forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC%), and the ratio of actual to predicted value of FEV1 (FEV1%pred), diffusing capacity of the lungs for carbon monoxide (DLCO%pred), difference value between alveolar air and arterial partial oxygen pressure (P(A−a) O2), and 6-minute walking distance test (6MWT), were assessed. Results: Findings revealed a significant association between elevated CDE and increased Hyp/Arg, increased P(A−a) O2, decreased 6MWT, DLCO%pred, and decreased FVC%pred. However, no statistically significant association was found between CDE and FEV1%pred or FEV1/FVC%. The mediating effect of Hyp/Arg was significant for CDE’s impact on P(A−a) O2 and DLCO%pred but not on 6MWT and FVC%pred. Conclusions: These results highlight the role of Hyp/Arg in mediating the association between CDE and lung function parameters, shedding light on potential therapeutic avenues for mitigating coal dust–induced lung function impairment.
- Open Access
- 28 June 2023
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 17 (7) , 684-693
Efficient clinical data analysis for prediction of coal workers' pneumoconiosis using machine learning algorithms
Purpose: The purpose of this study is to propose an efficient coal workers' pneumoconiosis (CWP) clinical prediction system and put it into clinical use for clinical diagnosis of pneumoconiosis.Methods: Patients with CWP and dust‐exposed workers who were enrolled from August 2021 to December 2021 were included in this study. Firstly, we chose the embedded method through using three feature selection approaches to perform the prediction analysis. Then, we performed the machine learning algorithms as the model backbone and combined them with three feature selection methods, respectively, to determine the optimal predictive model for CWP.Results: Through applying three feature selection approaches based on machine learning algorithms, it was found that AaDO2 and some pulmonary function indicators played an important role in prediction for identifying CWP of early stage. The support vector machine (SVM) algorithm was proved as the optimal machine learning model for predicting CWP, with the ROC curves obtained from three feature selection methods using SVM algorithm whose AUC values of 97.78%, 93.7%, and 95.56%, respectively.Conclusion: We developed the optimal model (SVM algorithm) through comparisons and analyses among the performances of different models for the prediction of CWP as a clinical application.
- 28 June 2023
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 17 (7) , 684-693
Open AccessEfficient clinical data analysis for prediction of coal workers' pneumoconiosis using machine learning algorithms
Purpose: The purpose of this study is to propose an efficient coal workers' pneumoconiosis (CWP) clinical prediction system and put it into clinical use for clinical diagnosis of pneumoconiosis.Methods: Patients with CWP and dust‐exposed workers who were enrolled from August 2021 to December 2021 were included in this study. Firstly, we chose the embedded method through using three feature selection approaches to perform the prediction analysis. Then, we performed the machine learning algorithms as the model backbone and combined them with three feature selection methods, respectively, to determine the optimal predictive model for CWP.Results: Through applying three feature selection approaches based on machine learning algorithms, it was found that AaDO2 and some pulmonary function indicators played an important role in prediction for identifying CWP of early stage. The support vector machine (SVM) algorithm was proved as the optimal machine learning model for predicting CWP, with the ROC curves obtained from three feature selection methods using SVM algorithm whose AUC values of 97.78%, 93.7%, and 95.56%, respectively.Conclusion: We developed the optimal model (SVM algorithm) through comparisons and analyses among the performances of different models for the prediction of CWP as a clinical application.
- Open Access
- 1 June 2023
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 18, 1319-1332
PIF1 Promotes Autophagy to Inhibit Chronic Hypoxia Induced Apoptosis of Pulmonary Artery Endothelial Cells
Purpose: Pulmonary artery hypertension (PAH) is a common complication of chronic obstructive pulmonary disease and obstructive sleep apnea/hypopnea syndrome worldwide. Pulmonary vascular alterations associated with PAH have multifactorial causes, in which endothelial cells play an important role. Autophagy is closely related to endothelial cell injury and the development of PAH. PIF1 is a multifunctional helicase crucial for cell survival. The present study investigated the effect of PIF1 on autophagy and apoptosis in human pulmonary artery endothelial cells (HPAECs) under chronic hypoxia stress. Methods: Chronic hypoxia Gene expression profiling chip-assays identified the PIF1 gene as differentially expressed, which was verified by RT-qPCR analysis. Electron microscopy, immunofluorescence, and Western blotting were used to analyze autophagy and the expression of LC3 and P62. Apoptosis was analyzed using flow cytometry. Results: Our study found that chronic hypoxia induces autophagy in HPAECs, and apoptosis was exacerbated by inhibiting autophagy. Levels of the DNA helicase PIF1 were increased in HPAECs after chronic hypoxia. PIF1 knockdown inhibited autophagy and promoted the apoptosis of HPAECs under chronic hypoxia stress. Conclusion: Based on these findings, we conclude that PIF1 inhibits the apoptosis of HPAECs by accelerating the autophagy pathway. Therefore, PIF1 plays a crucial role in HPAEC dysfunction in chronic hypoxia-induced PAH and may be a potential target for the treatment of PAH.
- 1 June 2023
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 18, 1319-1332
Open AccessPIF1 Promotes Autophagy to Inhibit Chronic Hypoxia Induced Apoptosis of Pulmonary Artery Endothelial Cells
Purpose: Pulmonary artery hypertension (PAH) is a common complication of chronic obstructive pulmonary disease and obstructive sleep apnea/hypopnea syndrome worldwide. Pulmonary vascular alterations associated with PAH have multifactorial causes, in which endothelial cells play an important role. Autophagy is closely related to endothelial cell injury and the development of PAH. PIF1 is a multifunctional helicase crucial for cell survival. The present study investigated the effect of PIF1 on autophagy and apoptosis in human pulmonary artery endothelial cells (HPAECs) under chronic hypoxia stress. Methods: Chronic hypoxia Gene expression profiling chip-assays identified the PIF1 gene as differentially expressed, which was verified by RT-qPCR analysis. Electron microscopy, immunofluorescence, and Western blotting were used to analyze autophagy and the expression of LC3 and P62. Apoptosis was analyzed using flow cytometry. Results: Our study found that chronic hypoxia induces autophagy in HPAECs, and apoptosis was exacerbated by inhibiting autophagy. Levels of the DNA helicase PIF1 were increased in HPAECs after chronic hypoxia. PIF1 knockdown inhibited autophagy and promoted the apoptosis of HPAECs under chronic hypoxia stress. Conclusion: Based on these findings, we conclude that PIF1 inhibits the apoptosis of HPAECs by accelerating the autophagy pathway. Therefore, PIF1 plays a crucial role in HPAEC dysfunction in chronic hypoxia-induced PAH and may be a potential target for the treatment of PAH.
- 1 April 2023
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 23 (10) , 921-930
Advances in Exosome Research in the Management of Lung Cancer
Lung cancer is one of the most common malignant tumors, and its death rate is much higher than that of colon, kidney, breast, and prostate cancers, and its 5-year survival rate is only 18%. Lung cancer has no specific clinical symptoms in its early stages and lacks effective detection, making early detection difficult. The survival rate for advanced lung cancer is meager, with a medi-an survival of only 12 months for stage IIIB/IV non-small cell lung cancer treated with platinum-based chemotherapy. Exosomes could provide vital information for the early diagnosis of lung can-cer and have the potential to become a tumor marker for lung cancer. In addition, scientists have proposed encouraging ways to treat lung cancer by loading drugs, proteins, microRNAs, and siR-NAs into exosomes. Therefore, studying lung cancer exosomes and exosomal nano drugs will pro-vide new ideas and approaches for the diagnosis and treatment of lung cancer. This paper reviews the progress of research on the biological functions of exosomes and exosomal nanomedicines and their applications in clinical practice.
- 1 April 2023
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 23 (10) , 921-930
Advances in Exosome Research in the Management of Lung Cancer
Lung cancer is one of the most common malignant tumors, and its death rate is much higher than that of colon, kidney, breast, and prostate cancers, and its 5-year survival rate is only 18%. Lung cancer has no specific clinical symptoms in its early stages and lacks effective detection, making early detection difficult. The survival rate for advanced lung cancer is meager, with a medi-an survival of only 12 months for stage IIIB/IV non-small cell lung cancer treated with platinum-based chemotherapy. Exosomes could provide vital information for the early diagnosis of lung can-cer and have the potential to become a tumor marker for lung cancer. In addition, scientists have proposed encouraging ways to treat lung cancer by loading drugs, proteins, microRNAs, and siR-NAs into exosomes. Therefore, studying lung cancer exosomes and exosomal nano drugs will pro-vide new ideas and approaches for the diagnosis and treatment of lung cancer. This paper reviews the progress of research on the biological functions of exosomes and exosomal nanomedicines and their applications in clinical practice.
- Open Access
- 15 March 2023
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 62 (5) , 1-21
Cyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G2/M phase transition regulatory network and the NFκB/JNK signaling pathway
Lung cancer is the leading cause of cancer‑related mortality worldwide. Non‑small cell lung cancer (NSCLC) is the most common pathological subtype of lung cancer and is associated with low 5‑year overall survival rates. Therefore, novel and effective chemotherapeutic drugs are urgently required for improving the survival outcomes of patients with lung cancer. Cyclovirobuxine D (CVB‑D) is a natural steroidal alkaloid, used for the treatment of cardiovascular diseases in Traditional Chinese Medicine. Several studies have also demonstrated the antitumor effects of CVB‑D. Therefore, in the present study, the therapeutic effects of CVB‑D in lung cancer and the underlying mechanisms were investigated using the in vivo xenograft model of NSCLC in nude mice and in vitro experiments with the NSCLC cell lines. Bioinformatics analyses of RNA‑sequencing data, and cell‑based functional assays demonstrated that CVB‑D treatment significantly inhibited in vitro and in vivo NSCLC cell proliferation, survival, invasion, migration, angiogenesis, epithelial‑to‑mesenchymal transition and G2/M phase cell cycle. CVB‑D exerted its antitumor effects by inhibiting the KIF11‑CDK1‑CDC25C‑cyclinB1 G2/M phase transition regulatory oncogenic network and the NF‑κB/JNK signaling pathway. CVB‑D treatment significantly reduced the sizes and weights and malignancy of xenograft NSCLC tumors in the nude mice. In conclusion, the present study demonstrated that CVB‑D inhibited the growth and progression of NSCLC cells by inhibiting the KIF11‑CDK1‑CDC25C‑CyclinB1 G2/M phase transition regulatory network and the NF‑κB/JNK signaling pathway. Therefore, CVB‑D is a promising drug for the treatment of NSCLC patients.
- 15 March 2023
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 62 (5) , 1-21
Open AccessCyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G2/M phase transition regulatory network and the NFκB/JNK signaling pathway
Lung cancer is the leading cause of cancer‑related mortality worldwide. Non‑small cell lung cancer (NSCLC) is the most common pathological subtype of lung cancer and is associated with low 5‑year overall survival rates. Therefore, novel and effective chemotherapeutic drugs are urgently required for improving the survival outcomes of patients with lung cancer. Cyclovirobuxine D (CVB‑D) is a natural steroidal alkaloid, used for the treatment of cardiovascular diseases in Traditional Chinese Medicine. Several studies have also demonstrated the antitumor effects of CVB‑D. Therefore, in the present study, the therapeutic effects of CVB‑D in lung cancer and the underlying mechanisms were investigated using the in vivo xenograft model of NSCLC in nude mice and in vitro experiments with the NSCLC cell lines. Bioinformatics analyses of RNA‑sequencing data, and cell‑based functional assays demonstrated that CVB‑D treatment significantly inhibited in vitro and in vivo NSCLC cell proliferation, survival, invasion, migration, angiogenesis, epithelial‑to‑mesenchymal transition and G2/M phase cell cycle. CVB‑D exerted its antitumor effects by inhibiting the KIF11‑CDK1‑CDC25C‑cyclinB1 G2/M phase transition regulatory oncogenic network and the NF‑κB/JNK signaling pathway. CVB‑D treatment significantly reduced the sizes and weights and malignancy of xenograft NSCLC tumors in the nude mice. In conclusion, the present study demonstrated that CVB‑D inhibited the growth and progression of NSCLC cells by inhibiting the KIF11‑CDK1‑CDC25C‑CyclinB1 G2/M phase transition regulatory network and the NF‑κB/JNK signaling pathway. Therefore, CVB‑D is a promising drug for the treatment of NSCLC patients.
- 9 December 2022
- Published by Elsevier in Science of The Total Environment
- Vol. 863, 160726
Cold spells linked with respiratory disease hospitalization, length of hospital stay, and hospital expenses: Exploring cumulative and harvesting effects
- 9 December 2022
- Published by Elsevier in Science of The Total Environment
- Vol. 863, 160726
Cold spells linked with respiratory disease hospitalization, length of hospital stay, and hospital expenses: Exploring cumulative and harvesting effects
- Open Access
- 15 July 2022
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 22 (1) , 1-14
Use data augmentation for a deep learning classification model with chest X-ray clinical imaging featuring coal workers' pneumoconiosis
Purpose: This paper aims to develop a successful deep learning model with data augmentation technique to discover the clinical uniqueness of chest X-ray imaging features of coal workers' pneumoconiosis (CWP). Patients and methods: We enrolled 149 CWP patients and 68 dust-exposure workers for a prospective cohort observational study between August 2021 and December 2021 at First Hospital of Shanxi Medical University. Two hundred seventeen chest X-ray images were collected for this study, obtaining reliable diagnostic results through the radiologists' team, and confirming clinical imaging features. We segmented regions of interest with diagnosis reports, then classified them into three categories. To identify these clinical features, we developed a deep learning model (ShuffleNet V2-ECA Net) with data augmentation through performances of different deep learning models by assessment with Receiver Operation Characteristics (ROC) curve and area under the curve (AUC), accuracy (ACC), and Loss curves. Results: We selected the ShuffleNet V2-ECA Net as the optimal model. The average AUC of this model was 0.98, and all classifications of clinical imaging features had an AUC above 0.95. Conclusion: We performed a study on a small dataset to classify the chest X-ray clinical imaging features of pneumoconiosis using a deep learning technique. A deep learning model of ShuffleNet V2 and ECA-Net was successfully constructed using data augmentation, which achieved an average accuracy of 98%. This method uncovered the uniqueness of the chest X-ray imaging features of CWP, thus supplying additional reference material for clinical application.
- 15 July 2022
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 22 (1) , 1-14
Open AccessUse data augmentation for a deep learning classification model with chest X-ray clinical imaging featuring coal workers' pneumoconiosis
Purpose: This paper aims to develop a successful deep learning model with data augmentation technique to discover the clinical uniqueness of chest X-ray imaging features of coal workers' pneumoconiosis (CWP). Patients and methods: We enrolled 149 CWP patients and 68 dust-exposure workers for a prospective cohort observational study between August 2021 and December 2021 at First Hospital of Shanxi Medical University. Two hundred seventeen chest X-ray images were collected for this study, obtaining reliable diagnostic results through the radiologists' team, and confirming clinical imaging features. We segmented regions of interest with diagnosis reports, then classified them into three categories. To identify these clinical features, we developed a deep learning model (ShuffleNet V2-ECA Net) with data augmentation through performances of different deep learning models by assessment with Receiver Operation Characteristics (ROC) curve and area under the curve (AUC), accuracy (ACC), and Loss curves. Results: We selected the ShuffleNet V2-ECA Net as the optimal model. The average AUC of this model was 0.98, and all classifications of clinical imaging features had an AUC above 0.95. Conclusion: We performed a study on a small dataset to classify the chest X-ray clinical imaging features of pneumoconiosis using a deep learning technique. A deep learning model of ShuffleNet V2 and ECA-Net was successfully constructed using data augmentation, which achieved an average accuracy of 98%. This method uncovered the uniqueness of the chest X-ray imaging features of CWP, thus supplying additional reference material for clinical application.